CR Bard Company Profile

12:02 EDT 22nd March 2018 | BioPortfolio

C. R. Bard, Inc. is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialty products. Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. Bard pioneered the development of single-patient-use medical products for hospital procedures; today Bard is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall costs.


730 Central Avenue
Murray Hill
New Jersey
United States of America


Phone: (908) 277-8000
Fax: (908) 277-8240

News Articles [27 Associated News Articles listed on BioPortfolio]

Stock Review for Medical Supplies Investors -- C.R. Bard, Glaukos, Waters, and Cooper C.R. Bard Murray Hill, New Jerseyheadquartered C.R. Bard Inc.'s stock finished Thursday's session 0.35% lower at $331.40with a total trading volume of Read mo...

$24B deal to buy C.R. Bard finalized by Becton Dickinson

The $24 billion acquisition of C.R. Bard has been completed by Becton Dickinson, making Bard its wholly owned subsidiary.  -More- 

C.R. Bard Declares Quarterly Dividend

MURRAY HILL, N.J.--(BUSINESS WIRE)--The Board of Directors of C. R. Bard, Inc. (NYSE-BCR) today declared a regular quarterly dividend of 26 cents per share on Bard's common stock. In conne...

Bard acquires female external catheter company PureWick for $30mm

CR Bard Inc. acquired private non-invasive female urological drainage device maker PureWick Inc. for up to $30mm.

BD Statement On MOFCOM Clearance Of Bard Acquisition

"MOFCOM clearance was the final regulatory approval needed to complete the Bard acquisition," said Vincent A. Forlenza, chairman and CEO of BD. "We look Read more...

China OKs Becton Dickinson's $24B C. R. Bard takeover

Becton Dickinson received approval from China's Ministry of Commerce for its proposed $24 billion acquisition of C. R. Bard.  -More- 

Extension of tender offer for Bard notes announced by BD

A tender offer for up to $1.1 billion in outstanding C. R. Bard notes has been extended again by Becton Dickinson from Oct.  -More- 

Merit Medical Coughs Up $100M for Bard, BD's Biopsy Assets

Merit's proposed asset acquisition is subject to the closing of BD’s proposed acquisition of Bard as well as other closing conditions.

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Cordran [Watson Pharma, Inc.]

Cordran® Tape Flurandrenolide Tape, USP For the Physician Rx only Revised: May 2010

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Size-Controllable Gold Nanopores with High SERS Activity.

Nanopore structures have been successfully employed in next generation DNA sequencing. For more complicated protein which normally contains 20 different amino acids, identifying the fluctuation of ion...

Clinical Trials [20 Associated Clinical Trials listed on BioPortfolio]

Study Of Hernia Repair Utilizing The Bard Ventrio Hernia Patch

This study will collect data on patients undergoing hernia repair using the Bard Ventrio Hernia Patch. The study will evaluate hernia recurrence rates, operating time, quality of life and...

Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent System

The medical device being examined in this study is the Bard® LifeStent® 5F Vascular Stent System. It is intended for use in patients who suffer from peripheral artery disease (PAD). PAD ...

A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries

To assess the safety and efficacy of the BARD LTX DCB for treatment of stenosis or occlusion of the superficial femoral and popliteal arteries.

The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent

This study will look at the performance of the Cordis S.M.A.R.T.™ CONTROL ™ Nitinol Stent System for the treatment of TASC C & D superficial femoral artery long lesions (up to 22 cm) i...

BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease

The BARD® Venovo™ Venous Stent Study is a non-randomized clinical study intended to collect confirmatory evidence of the safety and effectiveness of the Venous Stent for the treatment o...

Companies [13 Associated Companies listed on BioPortfolio]

CR Bard

C. R. Bard, Inc. is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialt...

C. R. Bard, Inc

C. R. Bard, Inc. is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialt...


The BISNAR | CHASE Orange County, California Bard Avaulta Mesh Lawyers represent people who have been very seriously injured or lost a family member due to defective products such...

C.R. Bard, Inc.

Bard Peripheral Vascular OEM Products

More Information about "CR Bard" on BioPortfolio

We have published hundreds of CR Bard news stories on BioPortfolio along with dozens of CR Bard Clinical Trials and PubMed Articles about CR Bard for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CR Bard Companies in our database. You can also find out about relevant CR Bard Drugs and Medications on this site too.

Quick Search


Relevant Topics

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record